Rachel Brody on Muck Rack

Rachel Brody

Verified
New York
As seen in: The New York Times, Nature, Newsweek, NPR, U.S. News and World Report, The Times of Israel, Cell Press, Cell Reports Medicine, The Appeal, Student Life, European Urology
Covers:  opinion, national news, breaking news
senior staff editor @nytimes flex desk. formerly @theappeal // @newsweek // @usnews. music words for @bowerypresents.

Get in touch with Rachel

Contact Rachel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Rachel Brody’s Biography

Read Full Bio →

I'm a New York-based opinion and news editor, interested in producing engaging and thought-provoking journalism. I've freelanced for Grist, The Appeal and #NewsNotNoise, and run the opinion section at Newsweek. Before that, I commissioned and edited op-eds for U.S. News & World Report.

Rachel Brody’s Journalist Portfolio

See all 9 portfolio items →
Why Has Police Sexual Misconduct Escaped the #MeToo Movement?

Why Has Police Sexual Misconduct Escaped the #MeToo Movement?

(Edit) As victims of sexual assault from the entertainment industry, Silicon Valley, the news business and ev…

View article →
Trump's Taxing Question

Trump's Taxing Question

Why won't Donald Trump release his tax returns?

View article →
Pot Is No Panacea

Pot Is No Panacea

Legal pot isn't a silver bullet.

View article →
Will South Carolina Feel the Bern?

Will South Carolina Feel the Bern?

Bernie Sanders won New Hampshire handily, but what lies ahead for him and Hillary Clinton?

View article →
The GOP Gets Down to Business

The GOP Gets Down to Business

The fourth GOP presidential debate, held Tuesday night and hosted by the Fox Business Network, abandoned the …

View article →
Clinton Goes After Guns

Clinton Goes After Guns

Democratic front-runner Hillary Clinton unveiled a plan Monday that calls for stricter gun control measures, …

View article →

Articles

Single-cell spatial transcriptomic analysis of human skin anatomy

|
By Paula Restrepo, Harkirat Singh Sandhu, Angie Ramirez, M. Grace Hren, Raman Gill, Abiha Kazmi, Larry Chen, Alexandra Nigro, Ichiro Imanishi, Deniz Demircioğlu, Dan Hasson, Alan Soto, Edgar Gonzalez-Kozlova, Rachel Brody , Benjamin Ungar, Maria Kasper, Catherine Lu , Philip Torina, Sacha Gnjatic, Sai Ma, Andrew L. Ji, Alexis Wilder, Aubrey Houser, Stephanie McQuillan
| Nature
Abstract The skin is the largest human organ and a site of substantial disease burden, yet its cellular and molecular organization across the body is largely undefined. Here we construct an organ-wide single-cell spatial atlas of ~1.2 million cells from normal adult human skin, resolving the location of 45 cell types across 114 samples encompassing 15 anatomic sites.
Open in Who Shared Issue with article?

Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart

|
By Jeffrey Downey, Ana Oliveira-Coelho, Máté G. Kiss, Gabriel Laghlali, Alexander Leunig, Emir Radkevich, Laszlo Halasz, Martin Umali, Madeline L Eller, Matteo Gianeselli, Haley E. Randolph, Gabriel Caumartin, Henrike Janssen, Laura L. Koekkoek, Jamshid Abdul-Ghafar, Pacific Huynh, Darwin D’Souza, Vladimir Roudko, Sheqouia A. Nauta, Jazz Munitz, Xisheng Li, Anh Phan, Ánh Phan, Abigail Ann Glick, Katarzyna I. Cialowicz, Zhihong Chen, Seunghee Kim-schulze, Matthias Nahrendorf, Susmita Sahoo, Miriam Merad, Adolfo Garcia-Sastre, Cameron S. McAlpine, Gustav J. Strijkers, Viviana Simon, Rachel Brody , Saurabh Mehandru, Zahi A. Fayad, Benjamin P. Kleinstiver, Lior Zangi, Michael Schotsaert, Filip K. Swirski, Thomas Rathner, Ziche Chen, Seonghun Yoon
| Cell Press
Keywords pro-DC3 type I interferon myeloid cells influenza heart cardiovascular disease Get full text access Log in, subscribe or purchase for full access. References 1. Falsey, A.R. ∙ Hennessey, P.A. ∙ Formica, M.A. ... Respiratory syncytial virus infection in elderly and high-risk adults N. Engl. J. Med. 2005; 352:1749-1759 2. Huang, L. ∙ Li, X. ∙ Gu, X. ... Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study Lancet Respir. Med. 2022; 10:863-876 3.
Open in Who Shared Issue with article?

Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer

|
By Sally E. Claridge, Majd Al Assaad, Eric Park, Julie-Ann Cavallo, Lamberto De Boni, Stacey Baker, Stephanie V. Blank, Olivier Elemento, Rachel Brody , Benjamin Hopkins, Shalini Nath, Genesis Lara Granados, Ufuoma Nuwere, Maame Esi Ackon, E. Premkumar Reddy
| Cell Reports Medicine
Keywords ovarian cancer rigosertib precision oncology high-throughput drug screening Kinome Atlas PI3K/MAPK signaling Introduction Ovarian cancer has a devastating impact, accounting for approximately 207,252 deaths and a total of 313,959 new cases worldwide in 2020.1 Data from the American Cancer Society estimated that 19,680 new ovarian cancer diagnoses and 12,740 fatalities will occur in the United States in 2024.2 Projections also suggest that, by 2040, the patient population with ovarian...
Open in Who Shared Issue with article?
See all 299 articles

Interview

When's the best time to pitch you?

Whenever the urge hits. I respond to email quickly, but you can contact me on Twitter for the speediest of replies.

Actions

Share this page

Get in touch with Rachel

Contact Rachel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified